Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-02-20
2007-02-20
Spector, Lorraine (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S300000, C530S380000, C536S023500
Reexamination Certificate
active
09798279
ABSTRACT:
This invention relates to nucleic acid encoding guinea pig PAR 4 and to the protein encoded thereby. The guinea pig DNA and protein are useful for the development of models of human platelet aggregation. The invention further relates to an animal model to assess the role of PAR antagonists in thrombosis.
REFERENCES:
patent: 6111075 (2000-08-01), Xu et al.
patent: WO 99/43809 (1999-09-01), None
patent: WO 99/50415 (1999-10-01), None
patent: WO02/070564 (2002-09-01), None
Nishikawa et al., Guinea pig platelets do not respond to GYPGKF, a protease-activated receptor-4-activating peptide: a property distinct from human platelets, Blood Coagulation and Fibrinolysis, 11:111-113, 2000.
Andrade-Gordon et al., Administration of a potent antagonist of protease-activated receptor (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats, J. Pharm. Exp. Therap. 298(1):34-42, 2001.
Al-Ani, B., Saifeddine, M., and Hollenberg, M. D. (1995). Detection of functional receptors for the proteinase-activated-receptor-2 activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle. Can. J. Phys. Pharmacol. 73, 1203-1207.
Cheung, W.-m., Andrade-Gordon, P., Derian, C. K., and Damiano, B. P. (1998). Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo. Can. J. Physiol. Pharmacol. 76, 16-25.
Connolly, A. J., Ishihara, H., Kahn, M. L., Farese Jr., R. V., and Coughlin, S. R. (1996). Role of the thrombin receptor in development and evidence for a second receptor. Nature 381, 516-519.
Connolly, T. M., Condra, C., Feng, D.-M., Cook, J. J., Stranieri, M. T., Reilly, C. F., Nutt, R. F., and Gould, R. J. (1994). Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb. Haemostasis 72, 627-33.
Darrow, A. L., Fung-Leung, W.-P., Ye R. D., Santulli, R. J., Cheung, W.-M., Derian, C. K., Burns, C. L., Damiano, B. P., Zhou, L., Keenan, C. M., Peterson, P. A., and Andrade-Gordon, P. (1996). Biological consequences of thrombin receptor deficiency in mice. Thromb. Haemostasis 76, 860-866.
Derian, C. K., Santulli, R. J., Tomko, K. A., Haertlein, B. J., and Andrade-Gordon, P. (1995). Species differences in platelet responses to thrombin and SFLLRN. Receptor-mediated calcium mobilization and aggregation, and regulation by protein kinases. Thromb. Res. 78, 505-19.
Gerszten, R. E., Chen, J., Ishii, M., Ishii, K., Wang, L., Nanevicz, T., Turck, C. W., Vu, T.-K. H., and Coughlin, S. R. (1994). Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature (London) 368, 648-51.
Hollenberg, M. D., Saifeddine, M., and Al-Ani, B. (1996). Proteinase-activated receptor-2 in rat aorta: Structural requirements for agonist activity of receptor-activating peptides. Mol. Pharmacol 49, 229-233.
Ishihara, H., Connolly, A. J., Zeng, D., Kahn, M. L., Zheng, Y. W., Timmons, C., Tram, T., and Couglin, S. R. (1997). Protease-activated receptor 3 is a second thrombin receptor in humans. Nature (London) 386, 502-506.
Kahn, M., Ishii, K., Kuo, W.-L., Piper, M., Connolly, A., Shi, Y.-P., Wu, R., Lin, C. C., and Coughlin, S. R. (1996). Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster. Mol. Med. (Cambridge, Mass.) 2, 349-357.
Kahn, M. L., Hammes, S. R., Botka, C., and Coughlin, S. R. (1998). Gene and locus structure and chromosomal localization of the protease-activated receptor gene family. J. Biol. Chem. 273, 23290-23296.
Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H., and Coughlin, S. R. (1999). Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103, 879-887.
Kahn, M. L., Zheng, Y.-W., Huang, W., Bigomia, V., Zeng, D., Moff, S., Farese, R. V., Jr., Tam, C., and Coughlin, S. R. (1998). A dual thrombin receptor system for platelet activation. Nature (London) 394, 690-694.
Kawabata, A., Kuroda, R., Minami, T., Kataoka, K., and Taneda, M. (1998). Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br. J. Pharmacol. 125, 419-422.
Li, F., Baykal, D., Horaist, C., Yan, C.-N., Carr, B. N., Rao, G. N., and Runge, M. S. (1996). Cloning and identification of regulatory sequences of the human thrombin receptor gene. J. Biol. Chem. 271, 26320-26328.
Nakanishi-Matsui, M., Zheng, Y.-W., Sulciner, D. J., Weiss, E. J., Ludeman, M. J., and Coughlin, S. R. (2000). PAR3 is a cofactor for PAR4 activation by thrombin. Nature (London) 404, 609-613.
Nishikawa, H., Kawabata, A., Kawai, K., and Kuroda, R. (2000). Guinea pig platelets do not respond to GYPGKF, a protease-activated receptor-4-activating peptide: a property distinct from human platelets. Blood Coagulation Fibrinolysis 11, 111-113.
Nystedt, S., Emilsson, K., Larsson, A.-K., Strombeck, B., and Sundelin, J. (1995). Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur. J. Biochem 232, 84-89.
Nystedt, S., Emilsson, K., Wahlestedt, C., and Sundelin, J. (1994). Molecular cloning of a potential proteinase activated receptor.Proc. Natl. Acad. Sci. USA 91,9208-9212.
Nystedt, S., Larsson, A.-K., Aberg, H., and Sundelin, J. (1996). The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression.J. Biol. Chem.270, 5950-5955.
Steinhoff, M., Vergnolle, N., Young, S. H., Tognetto, M., Arnadesi, S., Ennes, H. S., Trevisani, M., Hollenberg, M. D., Wallace, J. L., Caughey, G. H., Mitchell, S. E., Williams L. M., Geppetti, P., Mayer, E. A. and Bunnett, N. W. (2000). Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. (N.Y.) 6, 151-158.
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., and Coughlin, S. R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.Cell 64,1057-1068.
Xu, W.-F., Andersen, H., Whitmore, T. E., Presnell, S. R., Yee, D. P., Ching, A., Gilbert, T., Davie, E. W., and Foster, D. C. (1998). Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. U. S. A. 95, 6642-6646.
Zheng, X.-L., Renaux, B., and Hollenberg, M. D. (1998). Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inosital 3′-kinase. J. Pharmacol. Exp. Ther. 285, 325-334.
Addo Michael F.
Andrade-Gordon Patricia
Darrow Andrew L.
Derian Claudia K.
Kaufman Claire M.
Ortho-McNeil Pharmaceutical , Inc.
Spector Lorraine
LandOfFree
Guinea pig proteinase-activated receptor 4 and its... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guinea pig proteinase-activated receptor 4 and its..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guinea pig proteinase-activated receptor 4 and its... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3818930